The company, whose patent infringement claim led Apple to remove blood oxygen sensing tech from newer Apple Watches, has named Katie Szyman, worldwide president of Advanced Patient Monitoring at Becton Dickinson, for the role, The Wall Street Journal reports.
Interim CEO Michelle Brennan, who took over after CEO Joe Kiani resigned, will become the chair of Masimo’s board.






















